• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Dedicare: Political risk brought to mind in Q2 - ABG

DEDIThird party research20.07.2023 klo 10.18

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
• Two large regions in Sweden restrict staffing...
• ...causing challenges for the Swedish operations
• Change not fully offset by other markets

Q2: 11% organic sales growth y-o-y, -2% vs ABGSCe
Dedicare reported Q2 numbers below our expectations, with net sales of SEK 484m (+13% y-o-y) and adj. EBIT of SEK 34.4m (38.4m), corresponding to an adj. EBIT margin of 7.1% (9.0%). This was 2% and 17% below ABGSCe and the main explanation was the headwind in Sweden following the decision of the Stockholm and Sörmlands regions to restrict staffing for doctors and nurses. As a result, the Swedish operation was down 15% y-o-y in sales and profitability sharply declined versus last year. The Stockholm region in isolation was down 33% y-o-y in sales. Norway was also slightly behind our expectations but still grew 16% yo-y with solid profitability while Denmark continued its strong execution with sales up 68% y-o-y under improved margins. The Danish operation contributed with SEK 4.1m in EBIT in the quarter versus Sweden with SEK
4.7m.